Syntax Bio
Syntax Bio is a synthetic biology company programming the next generation of cell therapies. Its proprietary Cellgorithm platform uses a CRISPR-based system to accelerate and scale stem cell differentiation, transforming how regenerative medicines are discovered and manufactured. By replacing slow, manual differentiation processes with a rapid, programmable approach that mimics human development, Syntax makes cell generation faster, more reliable, and accessible, unlocking new transformative possibilities for biopharma developers and patients.
7-day free trial · no credit card
Verified contacts
12
available on Kipplo
LinkedIn employees
14
1 to 10 range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 12 verified contacts at Syntax Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
12 contacts with verified email or phone · masked until revealed.
- MM
Michaele McGregor
Associate Scientist · Research & Development
EmailPhone - BM
Brad Merrill
Head of Innovation · Science
EmailPhone - GM
Georgina Mancinelli
Research and Development Scientist · Research & Development
EmailPhone - RD
Renee de Pooter
Senior Scientist · Research & Development
EmailPhone - SA
Stephen Arnovitz
Scientist · Research & Development
EmailPhone
Showing 5 of 12 verified contacts
Top roles at Syntax Bio
7 distinct titles indexed · top 7 shown.
- 1associate scientist
- 1co-founder and scientific advisor
- 1head of innovation
- 1research and development scientist
- 1scientist
- 1senior scientist
- 1the ohio state university college of medicine
Sign up to unlock all 12 contacts at Syntax Bio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 12 verified contacts at Syntax Bio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.